Enfermedad renal crónica y transplante
ERYTRA
Mayo Clinic
Rochester, Estados UnidosPublicaciones en colaboración con investigadores/as de Mayo Clinic (9)
2024
-
International consensus on post-transplantation diabetes mellitus
Nephrology Dialysis Transplantation
2023
-
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2
Kidney International, Vol. 103, Núm. 1, pp. 207-217
2021
-
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients
Kidney International, Vol. 99, Núm. 3, pp. 671-685
2016
-
Assessment of urine proteomics in type 1 primary hyperoxaluria
American Journal of Nephrology, Vol. 43, Núm. 4, pp. 293-303
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2095-2128
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196
2009
-
Primary hyperoxaluria type 1: Update and additional mutation analysis of the AGXT gene
Human Mutation, Vol. 30, Núm. 6, pp. 910-917
-
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis
Nephrology Dialysis Transplantation, Vol. 24, Núm. 10, pp. 3089-3096